Literature DB >> 24876735

Pulmonary metastasectomy for colorectal cancer: how many nodules, how many times?

Hong Kwan Kim1, Jong Ho Cho1, Ho Yun Lee1, Jeeyun Lee1, Jhingook Kim1.   

Abstract

Colorectal cancer (CRC) is one of the most common cancers worldwide, with 5%-15% of CRC patients eventually developing lung metastasis (LM). Despite doubts about the role of locoregional therapy in the management of systemic disease, many surgeons have performed pulmonary metastasectomy (PM) for CRC in properly selected patients. However, the use of pulmonary metastasectomy remains controversial due to the lack of randomized controlled studies. This article reviews the results of surgical treatment of pulmonary metastases for CRC, focusing on (1) current treatment guidelines and surgical techniques of PM in patients with LM from CRC; (2) outcomes of PM and its prognostic factors; and (3) controversial issues in PM, focusing on repeated metastasectomy, bilateral multiple metastases, and combined liver and lung metastasectomy.

Entities:  

Keywords:  Colorectal cancer; Metastases; Pulmonary metastasectomy; Surgery

Mesh:

Substances:

Year:  2014        PMID: 24876735      PMCID: PMC4033452          DOI: 10.3748/wjg.v20.i20.6133

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  113 in total

1.  Early intrapulmonary recurrence after pulmonary metastasectomy related to colorectal cancer.

Authors:  Mi Ri Hwang; Ji Won Park; Dae Yong Kim; Hee Jin Chang; Sun Young Kim; Hyo Seong Choi; Moon Soo Kim; Jae Ill Zo; Jae Hwan Oh
Journal:  Ann Thorac Surg       Date:  2010-08       Impact factor: 4.330

2.  Lung metastasectomy in colorectal cancer: is this surgery effective in prolonging life?

Authors:  John Primrose; Tom Treasure; Francesca Fiorentino
Journal:  Respirology       Date:  2010-04-23       Impact factor: 6.424

3.  Efficacy according to biomarker status of cetuximab plus FOLFOX-4 as first-line treatment for metastatic colorectal cancer: the OPUS study.

Authors:  C Bokemeyer; I Bondarenko; J T Hartmann; F de Braud; G Schuch; A Zubel; I Celik; M Schlichting; P Koralewski
Journal:  Ann Oncol       Date:  2011-01-12       Impact factor: 32.976

4.  Survival after lung metastasectomy for colorectal cancer: importance of previous liver metastasis as a prognostic factor.

Authors:  J Zabaleta; B Aguinagalde; M G Fuentes; N Bazterargui; J M Izquierdo; C J Hernández; J M Enriquez-Navascués; J I Emparanza
Journal:  Eur J Surg Oncol       Date:  2011-07-02       Impact factor: 4.424

5.  Repeat resection of pulmonary metastasis is beneficial for patients with colorectal carcinoma.

Authors:  Fengshi Chen; Hiroaki Sakai; Ryo Miyahara; Toru Bando; Kenichi Okubo; Hiroshi Date
Journal:  World J Surg       Date:  2010-10       Impact factor: 3.352

6.  Results of a pulmonary metastasectomy in patients with colorectal cancer.

Authors:  Ryuichi Suemitsu; Sadanori Takeo; Eiji Kusumoto; Motoharu Hamatake; Koji Ikejiri; Hideki Saitsu
Journal:  Surg Today       Date:  2010-12-30       Impact factor: 2.549

7.  Cancer statistics, 2012.

Authors:  Rebecca Siegel; Deepa Naishadham; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2012-01-04       Impact factor: 508.702

8.  Role of surgical resection in colorectal lung metastases: analysis of 137 patients.

Authors:  Piero Borasio; Mara Gisabella; Andrea Billé; Luisella Righi; Marina Longo; Marco Tampellini; Francesco Ardissone
Journal:  Int J Colorectal Dis       Date:  2010-10-20       Impact factor: 2.571

9.  Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation status.

Authors:  Eric Van Cutsem; Claus-Henning Köhne; István Láng; Gunnar Folprecht; Marek P Nowacki; Stefano Cascinu; Igor Shchepotin; Joan Maurel; David Cunningham; Sabine Tejpar; Michael Schlichting; Angela Zubel; Ilhan Celik; Philippe Rougier; Fortunato Ciardiello
Journal:  J Clin Oncol       Date:  2011-04-18       Impact factor: 44.544

10.  Short disease-free interval is a significant risk factor for intrapulmonary recurrence after resection of pulmonary metastases in colorectal cancer.

Authors:  Y Takakura; Y Miyata; M Okajima; M Okada; Hideki Ohdan
Journal:  Colorectal Dis       Date:  2009-10-19       Impact factor: 3.788

View more
  19 in total

1.  CT-guided percutaneous radiofrequency ablation for lung metastases from colorectal cancer.

Authors:  Yukiharu Hiyoshi; Yuji Miyamoto; Yuki Kiyozumi; Hiroshi Sawayama; Kojiro Eto; Yohei Nagai; Masaaki Iwatsuki; Shiro Iwagami; Yoshifumi Baba; Naoya Yoshida; Koichi Kawanaka; Yasuyuki Yamashita; Hideo Baba
Journal:  Int J Clin Oncol       Date:  2018-10-17       Impact factor: 3.402

2.  Surgery of colorectal cancer lung metastases: analysis of survival, recurrence and re-surgery.

Authors:  Francesco Guerrera; Claudio Mossetti; Manuela Ceccarelli; Maria Cristina Bruna; Giulia Bora; Stefania Olivetti; Paolo Olivo Lausi; Paolo Solidoro; Giovannino Ciccone; Enrico Ruffini; Alberto Oliaro; Pier Luigi Filosso
Journal:  J Thorac Dis       Date:  2016-07       Impact factor: 2.895

3.  Insurance Status and Hospital Payer Mix Are Linked With Variation in Metastatic Site Resection in Patients With Advanced Colorectal Cancers.

Authors:  Mark A Healy; Jason C Pradarelli; Robert W Krell; Scott E Regenbogen; Pasithorn A Suwanabol
Journal:  Dis Colon Rectum       Date:  2016-11       Impact factor: 4.585

4.  Rate of pulmonary metastasis varies with location of rectal cancer in the patients undergoing curative resection.

Authors:  Jong Lyul Lee; Chang Sik Yu; Tae Won Kim; Jong Hoon Kim; Jin Cheon Kim
Journal:  World J Surg       Date:  2015-03       Impact factor: 3.352

5.  Editorial on "Growth patterns of pulmonary metastases: should we adjust resection techniques to primary histology and size?"

Authors:  Stefano M M Basso; Sandro C Sulfaro; Paolo Ubiali
Journal:  J Thorac Dis       Date:  2018-01       Impact factor: 2.895

Review 6.  Systemic Versus Local Therapies for Colorectal Cancer Pulmonary Metastasis: What to Choose and When?

Authors:  Tony Ibrahim; Lambros Tselikas; Charbel Yazbeck; Joseph Kattan
Journal:  J Gastrointest Cancer       Date:  2016-09

7.  [Liver and lung metastases of colorectal cancer. Long-term survival and prognostic factors].

Authors:  S Sponholz; S Bölükbas; M Schirren; S Oguzhan; N Kudelin; J Schirren
Journal:  Chirurg       Date:  2016-02       Impact factor: 0.955

8.  Suppression of lung metastases by the CD26/DPP4 inhibitor Vildagliptin in mice.

Authors:  Jae-Hwi Jang; Lesley Baerts; Yannick Waumans; Ingrid De Meester; Yoshito Yamada; Perparim Limani; Ignacio Gil-Bazo; Walter Weder; Wolfgang Jungraithmayr
Journal:  Clin Exp Metastasis       Date:  2015-08-02       Impact factor: 5.150

Review 9.  Adjuvant chemotherapy for resected colorectal cancer metastases: Literature review and meta-analysis.

Authors:  Giovanni Brandi; Stefania De Lorenzo; Margherita Nannini; Stefania Curti; Marta Ottone; Filippo Gustavo Dall'Olio; Maria Aurelia Barbera; Maria Abbondanza Pantaleo; Guido Biasco
Journal:  World J Gastroenterol       Date:  2016-01-14       Impact factor: 5.742

10.  Development and validation of risk and prognostic nomograms for bone metastases in Chinese advanced colorectal cancer patients.

Authors:  Nan Wang; Fangqi Liu; Wenqi Xi; Jinling Jiang; Yun Xu; Bingjie Guan; Junwei Wu; Chenfei Zhou; Min Shi; Zhenggang Zhu; Ye Xu; Jing Liu; Jun Zhang
Journal:  Ann Transl Med       Date:  2021-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.